Search results for "Crohn's Disease."

showing 10 items of 234 documents

Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease.

2014

Background & Aims Treatment with immunosuppressive thiopurines such as azathioprine is associated with an increased risk of leukemogenesis. We assessed the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndromes, in a large cohort of patients with inflammatory bowel disease (IBD) in France. Methods We performed a prospective observational study of 19,486 patients with IBD enrolled in the Cancers Et Surrisque Associe aux Maladies inflammatoires intestinales En France (CESAME) study from May 2004 through June 2005; patients were followed through December 31, 2007. The incidence of myeloid disorders in the general population, which was used for reference, was de…

AdultMalemedicine.medical_specialtyMyeloidAdolescentPopulationAzathioprineRisk AssessmentInflammatory bowel diseaseCohort StudiesYoung Adult[ CHIM.ORGA ] Chemical Sciences/Organic chemistryInternal medicinehemic and lymphatic diseasesAzathioprinemedicineHumansProspective Studieseducationeducation.field_of_studyCrohn's diseaseHepatologyThiopurine methyltransferasebiologybusiness.industry[CHIM.ORGA]Chemical Sciences/Organic chemistryIncidenceMyelodysplastic syndromesGastroenterologyMyeloid leukemiaMiddle AgedInflammatory Bowel Diseasesmedicine.disease3. Good healthLeukemia Myeloid Acutemedicine.anatomical_structureMyelodysplastic SyndromesImmunologybiology.proteinFemaleFrancebusinessImmunosuppressive Agentsmedicine.drug
researchProduct

Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA e…

2012

BACKGROUND AIMS Triggering receptor expressed on myeloid cells 1 (TREM 1) is a potent amplifier of pro inflammatory responses. We have previously demonstrated a substantial increase in TREM 1 expressing macrophages in the inflamed intestinal mucosa of patients with inflammatory bowel diseases (IBD). TREM 1 is also produced as a soluble receptor (sTREM 1). Here we aimed to determine whether serum sTREM 1 could be used as a surrogate marker of disease activity in patients with IBD. METHODS Intestinal biopsies and concurrently collected sera from patients with Crohn's disease (CD) and Ulcerative colitis (UC) enrolled in the Swiss IBD cohort study were analyzed for intestinal TREM 1 mRNA and se…

AdultMalemedicine.medical_specialtyMyeloidColonGastroenterologyInflammatory bowel diseaseEndoscopy GastrointestinalStatistics Nonparametric03 medical and health sciencesMice0302 clinical medicineIntestinal mucosaCrohn DiseaseIleumInternal medicinemedicineAnimalsHumansRNA MessengerColitisReceptors ImmunologicReceptor030304 developmental biology0303 health sciencesCrohn's diseaseMessenger RNAMembrane Glycoproteinsbusiness.industryGastroenterologyGeneral MedicineMiddle Agedmedicine.diseaseUlcerative colitisAdoptive Transferdigestive system diseasesTriggering Receptor Expressed on Myeloid Cells-13. Good healthmedicine.anatomical_structureROC CurveArea Under CurveImmunologyColitis UlcerativeFemalebusinessBiomarkers030215 immunologyJournal of Crohn's & colitis
researchProduct

Laparoscopic ileocecal resection in acute and chronic presentations of Crohn's disease. A single center experience

2017

Introduction The terminal ileum is the most involved tract in Crohn's disease. The obstruction in this location is the most frequent complication. Acute or chronic presentations can occur. Surgery finds a role in the management of chronic strictures and in acute clinical presentations with complications not improving with conservative therapy. Patients and methods We investigate the outcome of patients with obstruction of the ileo-cecal bowel tract laparoscopically managed. It was analyzed the average operative time (OT), the conversion rate and the occurrence of re-operation due to surgical complications. Results 21 patients underwent an ileocecal resection for complicated Crohn's disease …

AdultMalemedicine.medical_specialtyOperative TimeAnastomotic LeakAnastomosisClinical PracticeHospitals University03 medical and health sciencesIleocecal valve0302 clinical medicineCrohn DiseaseRisk FactorsRetrospective StudiemedicineHumansHemoperitoneumLaparoscopyRetrospective StudiesAcute Disease; Adult; Anastomosis Surgical; Anastomotic Leak; Chronic Disease; Conversion to Open Surgery; Crohn Disease; Female; Hospitals University; Humans; Ileal Diseases; Ileocecal Valve; Intestinal Obstruction; Length of Stay; Male; Operative Time; Retrospective Studies; Risk Factors; Treatment Outcome; LaparoscopyCrohn's diseaseIleocecal Valvemedicine.diagnostic_testbusiness.industryIleal DiseasesGeneral surgeryMortality rateRisk FactorAnastomosis SurgicalRetrospective cohort studyLength of Staymedicine.diseaseConversion to Open SurgerySurgerymedicine.anatomical_structureTreatment Outcome030220 oncology & carcinogenesisAcute DiseaseChronic DiseaseIleal Disease030211 gastroenterology & hepatologyFemaleLaparoscopymedicine.symptombusinessComplicationIntestinal ObstructionHuman
researchProduct

Incidence of Crohn's disease and CARD15 mutation in a small township in Sicily.

2006

Background: The incidence of Crohn's disease (CD) has been shown to be lower in Southern than in Northern Europe. Data on the frequency of the NOD2/CARD15 mutations for Mediterranean area are very scant. Aim: To determine the incidence of CD from 1979 to 2002 in a township in Sicily together with the allele frequency of NOD2/CARD15 mutations in patients, family members and controls, and to determine the allele frequency of these mutations in sporadic CD from other areas of Sicily in comparison with a control population. Methods: Casteltermini is a small town close to Agrigento (Sicily) with a population of 9,130 inhabitants. All the diagnoses of inflammatory bowel disease (IBD) made from 19…

AdultMalemedicine.medical_specialtyPathologyAdolescentEpidemiologyPopulationNod2 Signaling Adaptor ProteinInflammatory bowel diseaseGastroenterologyCrohn DiseaseGene FrequencyInternal medicineEpidemiologyPrevalencemedicineHumansGenetic Predisposition to DiseaseRisk factoreducationAllele frequencySicilyNOD2/CARD15Crohn's diseaseeducation.field_of_studybusiness.industryIncidence (epidemiology)IncidenceMiddle Agedmedicine.diseaseUlcerative colitisdigestive system diseasesCrohn's diseaseMutationColitis UlcerativeFemalebusinessEuropean journal of epidemiology
researchProduct

Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease.

1985

Intestinal alpha 1-antitrypsin clearance was quantified in 17 patients with clinically active Crohn's disease before and after a six-week period of treatment with sulfasalazine and methylprednisolone. Before the study, alpha 1-antitrypsin clearance and, hence, enteric protein loss was elevated as being above control values in 16 patients. After therapy, clearance values decreased in 11 and were normalized in five patients. Serum albumin level was normalized in 11 of 12 patients who had hypoalbuminemia before the study. Clinical condition was improved in all but 1 patient after treatment. There was no close correlation between alpha 1-antitrypsin clearance and disease activity index. These r…

AdultMalemedicine.medical_specialtyPathologyAdolescentPhysiologyProtein-Losing EnteropathiesSerum albuminAnti-Inflammatory AgentsGastroenterologyMethylprednisoloneFecesCrohn DiseaseSulfasalazineInternal medicinemedicineHumansHypoalbuminemiaIntestinal MucosaSerum AlbuminCrohn's diseasebiologybusiness.industryProtein losing enteropathyGastroenterologyAlbuminHepatologyMiddle Agedmedicine.diseasedigestive system diseasesSulfasalazineMethylprednisolonealpha 1-Antitrypsinbiology.proteinFemalebusinessmedicine.drugDigestive diseases and sciences
researchProduct

Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Diseas…

2004

Abstract Background. Three variants of the NOD 2 /CARD 15 gene are strongly associated with susceptibility to Crohn’s disease; however, striking racial and geographic differences of their frequency have been described. Aims. We have compared the allele frequencies of familial cases of Crohn’s disease recruited in a multicentre study across Italy, in order to disclose possible geographic heterogeneity. Moreover, we also compared the allele frequencies in sporadic cases of Crohn’s disease and healthy controls from Southern Italy with those reported in other two populations from Central and Northern Italy. Subjects and Methods. A total of 731 subjects were genotyped for the polymorphism of thr…

AdultMalemedicine.medical_specialtyPathologyGenotypeNod2 Signaling Adaptor ProteinDiseaseInflammatory bowel diseaseGastroenterologyInflammatory bowel diseaseNOD2Frameshift mutationGeneticCrohn DiseaseGene FrequencyPolymorphism (computer science)NOD2Internal medicineMedicineHumansGenetic Predisposition to DiseaseCARD15Frameshift MutationAllele frequencyAgedCrohn's diseasePolymorphism GeneticHepatologybusiness.industrySignificant differenceGastroenterologyIntracellular Signaling Peptides and ProteinsMiddle Agedmedicine.diseaseCrohn's diseaseItalyFemalebusinessCarrier Proteins
researchProduct

Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease

2016

Background: An accurate assessment of the inflammatory activity is crucial to establish the most appropriate treatment in Crohn's disease (CD). The present study aimed to evaluate the utility of preoperative fecal calprotectin (FC) measurement in small bowel CD and its relationship with inflammatory activity in surgical pathology specimens. Methods: This was a prospective observational study including all the patients with small bowel CD operated on at our center between March 2011 and September 2013. Preoperative laboratory and stool tests were performed. A meticulous exploration of entire small bowel was performed during surgery, and the resected bowel (or a sample of whole intestinal wal…

AdultMalemedicine.medical_specialtyPathologymedicine.medical_treatmentInflammationGastroenterologySensitivity and SpecificitySeverity of Illness IndexSurgical pathology03 medical and health sciencesFeces0302 clinical medicineFecal calprotectinCrohn DiseaseInternal medicineIntestine SmallmedicineStrictureplastyHumansProspective StudiesSurgical pathologyProspective cohort studyAgedAged 80 and overCrohn's diseaseLeukocyte L1 Antigen Complexbusiness.industryBiomarkerMiddle Agedmedicine.diseaseSmall bowel Crohn's disease030220 oncology & carcinogenesisPreoperative PeriodBiomarker (medicine)030211 gastroenterology & hepatologySurgeryFemalemedicine.symptomCalprotectinbusinessLeukocyte L1 Antigen ComplexBiomarkers
researchProduct

Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin.

2006

1. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1117-25. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Prantera C, Lochs H, Campieri M, Scribano ML, Sturniolo GC, Castiglione F, Cottone M. Operative Unit of Gastroenterology, St Camillo-Forlanini Hospital, Rome, Italy. prantera@tin.it BACKGROUND: Clinicians often employ antibiotics in Crohn's disease. Rifaximin is active against bacteria frequently found in the intestinal mucosa of Crohn's disease patients. AIM: To evaluate the difference in efficacy between once and twice/daily oral administration of rifaximin and placebo in the treatment of active Crohn's …

AdultMalemedicine.medical_specialtyPlacebo-controlled studyCIPROFLOXACINPlaceboGastroenterologyInflammatory bowel diseaseDrug Administration ScheduleRifaximinPlaceboschemistry.chemical_compoundCrohn DiseaseDouble-Blind MethodIntestinal mucosaINFLAMMATORY-BOWEL-DISEASE C-REACTIVE PROTEIN ULCERATIVE-COLITIS METRONIDAZOLE CIPROFLOXACIN MANAGEMENT RECURRENCE DIARRHEA ANTIBODY MODERATEInternal medicinemedicineMANAGEMENTHumansPharmacology (medical)RECURRENCEAntibacterial agentCrohn's diseaseChi-Square DistributionHepatologybusiness.industryGastroenterologyMiddle Agedmedicine.diseaseRifamycinsUlcerative colitisDIARRHEAC-REACTIVE PROTEINAnti-Bacterial AgentsSurgeryRifaximinTreatment OutcomechemistryULCERATIVE-COLITISANTIBODYMETRONIDAZOLEAcute Diseaserifaximin.crohn's diseaseMODERATEFemalebusinessINFLAMMATORY-BOWEL-DISEASE
researchProduct

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

2012

International audience; BACKGROUND: It remains to be shown whether inflammatory bowel disease (IBD) is associated with an increased risk of primary intestinal lymphoproliferative disorders (PILD). We assessed this risk in the CESAME French nationwide prospective observational cohort. METHODS: In all, 680 gastroenterologists enrolled 19,486 patients with IBD (Crohn's disease in 60.3%) from May 2004 to June 2005. Follow-up ended on 31 December 2007. Available biopsy samples and surgical specimens from patients with PILD (n = 14) were centralized for review. The reference incidence of PILD in the general population was obtained from the Côte d'Or registry and was used as a comparator to assess…

AdultMalemedicine.medical_specialtyPopulationGastroenterologyInflammatory bowel diseaseYoung Adult03 medical and health sciences0302 clinical medicineCrohn DiseaseInterquartile range[ CHIM.ORGA ] Chemical Sciences/Organic chemistryInternal medicineAzathioprinemedicineHumansImmunology and AllergyProspective StudiesChildeducationAgedAged 80 and overeducation.field_of_studyCrohn's diseaseThiopurine methyltransferasebiologyMercaptopurinebusiness.industry[CHIM.ORGA]Chemical Sciences/Organic chemistryIncidenceIncidence (epidemiology)GastroenterologyCase-control studyOdds ratioMiddle Agedmedicine.diseaseLymphoproliferative Disorders3. Good healthTreatment OutcomeCase-Control Studies030220 oncology & carcinogenesisbiology.proteinColitis UlcerativeFemale030211 gastroenterology & hepatologyFrancebusinessImmunosuppressive AgentsFollow-Up Studies
researchProduct

MR imaging of perianal fistulas in Crohn's disease: Sensitivity and specificity of STIR sequences

2015

Introduction Although some studies proved the role of STIR sequences in the evaluation of perianal fistulas in Crohn's Disease (CD), contrast medium is still injected in many institutions since there is not a validated reference MR protocol. Our purpose was to evaluate the role of the STIR sequence in the detection and characterization of perianal fistulae comparing it to the post-contrast T1 sequence and correlating it with rectal examination under anesthesia. Materials and methods We retrospectively reviewed all clinical records of 31 CD patients, suspected of having perianal fistulas, who had been submitted to an MR study before and after contrast medium injection and surgical exploratio…

AdultMalemedicine.medical_specialtyRadiology Nuclear Medicine and ImagingFistulaCrohn's DiseaseInflammatory bowel diseaseInflammatory bowel disease030218 nuclear medicine & medical imaging03 medical and health sciencesYoung Adult0302 clinical medicineCrohn DiseaseRetrospective StudieMedicineHumansRectal FistulaNeuroradiologyRetrospective StudiesCrohn's diseasemedicine.diagnostic_testbusiness.industryMedicine (all)Magnetic resonance imagingInterventional radiologyGeneral MedicineRectal examinationSTIRMiddle Agedmedicine.diseaseMagnetic Resonance ImagingContrast medium030211 gastroenterology & hepatologyFemaleRadiologybusinessHuman
researchProduct